Plasma Cell Leukemia — Trials

Plasma Cell Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

53 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 23
Recruiting: 16
Ph III recruiting: 1
Growth YoY: —
Industry share: 9%
Top sponsor: Institute of Hematology & Blood Diseases Hospital, China
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (6)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05870917	A Study of VRD-based Regimen Combined With CART-ASCT-CART2 Treatment in Patients With Primary Plasma Cell Leukemia	active not recruiting	Phase 2	20	Institute of Hematology & Blood Diseases Hospital, ChinaOTHER	1	Jul 1, 2026	clinicaltrials
NCT02334865	SVN53-67/M57-KLH Peptide Vaccine in Treating Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide Maintenance Therapy	active not recruiting	Phase 1	18	Roswell Park Cancer InstituteOTHER	1	May 15, 2026